Kiribati vs Sao Tome and Principe: Hepatitis B surface antigen (HBsAg) prevalence
Kiribati
0.9%
in 2024
Sao Tome and Principe
0.8%
in 2024
Kiribati rank
36th
Sao Tome and Principe rank
39th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Kiribati
- Sao Tome and Principe
How they compare
Kiribati currently reports 0.9% against 0.8% in Sao Tome and Principe, a difference of 0.1%.
That makes Kiribati's figure about 1.1 times Sao Tome and Principe's.
Across all 10 years both countries report, Kiribati has been ahead every year.
Kiribati ranks 36th and Sao Tome and Principe ranks 39th of 194 countries.
Kiribati has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 0.9% | 1.0% | Kiribati |
| 2020s | 1.1% | 0.8% | 0.3% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Kiribati or Sao Tome and Principe?
- Kiribati, at 0.9% against 0.8% in Sao Tome and Principe as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Kiribati and Sao Tome and Principe?
- 0.1%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Sao Tome and Principe?
- 10 years are reported by both, from 2015 to 2024.
- How do Kiribati and Sao Tome and Principe rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Kiribati ranks 36th and Sao Tome and Principe ranks 39th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.